Long non-coding RNA MVIH acts as a prognostic marker in glioma and its role in cell migration and invasion

OBJECTIVE

High expression levels of lncRNA associated with microvascular invasion in HCC (lncRNA MVIH) were found to correlate with several solid tumors. However, little is known concerning the function of MVIH in glioma. The purpose of our study is to explore the role of lncRNA MVIH in clinical glioma samples and cell lines.

PATIENTS AND METHODS

The expression levels of MVIH were analyzed in glioma surgical resection tissues and cells by RT-PCR. Additionally, the associations of MVIH expression with clinicopathological features were analyzed. Survival and Cox proportional-hazards regression analyses were performed to determine the correlation between MVIH expression levels and prognosis in the patients. The cell proliferation, migration ability, invasion ability were measured successively by CKK-8 assay, transwell and wound healing assay.

RESULTS

We found that MVIH was significantly upregulated in glioma cell lines and tissues. Furthermore, MVIH expression was positively correlated with KPS and WHO grade. Patients with MVIH high expression tumors had a worse overall survival compared to patients with MVIH high expression tumors. Moreover, Univariate and multivariate Cox regression analysis confirmed that MVIH was an independent risk factor for glioma. Finally, in vitro, we showed that up-regulation of MVIH expression promoted human glioma cells proliferation, invasion and migration, while down-regulation of MVIH expression suppressed human glioma cells proliferation, invasion and migration.

CONCLUSIONS

Our findings indicated that MVIH expression may serve not only as a prognostic marker but also as a potential therapeutic target in glioma.

The ultra early diagnosis of Parkinson's disease by the enhanced substantia nigra echo

OBJECTIVE

Our objective is to determine the value of enhanced substantia nigra echo in the diagnosis of Parkinson's disease by analyzing the intensity and area of substantia nigra echo by transcranial Doppler sonography (TCS).

PATIENTS AND METHODS

36 patients diagnosed as ultra early stage Parkinson's disease between 2013 November and 2014 August were selected as the disease group, and 32 healthy people with the similar representation of age and gender were selected as the control group. TCS was used to detect the echo intensity and the echo intensity of the same location of bilateral hemicerebrum was used to evaluate the bilateral substantia nigra echo. The age and gender were also used for correlation analysis with the results of substantia nigra echo.

RESULTS

In the control group, there were 17 patients of substantia nigra echo grade I (53.1%), 13 cases of substantia nigra echo grade II (40.6%), 2 cases of substantia nigra echo grade III (6.3%). While in the disease group, there were 4 cases of substantia nigra echo grade II (11.1%), 13 cases of substantia nigra echo grade III (36.1%), 12 cases of substantia nigra echo grade IV (33.3%) and 7 cases of substantia nigra echo grade V (19.4%). The ratio of enhanced substantia nigra echo in Parkinson's disease patients was significantly higher than the control group. The analysis of the factors related to motor symptoms in Parkinson's disease patients revealed that the area of bilateral substantia nigra echo was negatively correlated with gender, but positively correlated with age, S/M ratio and UPDRS II score. However, there was no correlation with H-Y stage. The sensitivity of substantia nigra echo in diagnosing Parkinson's disease was 32/36=88.89% and the specificity was 30/32 = 93.75%.

CONCLUSIONS

Analysis of substantia nigra echo is practically useful for the diagnosis of the ultra early stage Parkinson's disease, which can potentially improve the accuracy of clinical diagnosis to significantly enhance the early clinical prevention and reduce later disability.

The Genome Sequence DataBase: towards an integrated functional genomics resource

During 1998 the primary focus of the Genome Sequence DataBase (GSDB; http://www.ncgr.org/gsdb ) located at the National Center for Genome Resources (NCGR) has been to improve data quality, improve data collections, and provide new methods and tools to access and analyze data. Data quality has been improved by extensive curation of certain data fields necessary for maintaining data collections and for using certain tools. Data quality has also been increased by improvements to the suite of programs that import data from the International Nucleotide Sequence Database Collaboration (IC). The Sequence Tag Alignment and Consensus Knowledgebase (STACK), a database of human expressed gene sequences developed by the South African National Bioinformatics Institute (SANBI), became available within the last year, allowing public access to this valuable resource of expressed sequences. Data access was improved by the addition of the Sequence Viewer, a platform-independent graphical viewer for GSDB sequence data. This tool has also been integrated with other searching and data retrieval tools. A BLAST homology search service was also made available, allowing researchers to search all of the data, including the unique data, that are available from GSDB. These improvements are designed to make GSDB more accessible to users, extend the rich searching capability already present in GSDB, and to facilitate the transition to an integrated system containing many different types of biological data.

The Genome Sequence DataBase (GSDB): improving data quality and data access

In 1997 the primary focus of the Genome Sequence DataBase (GSDB; www. ncgr.org/gsdb ) located at the National Center for Genome Resources was to improve data quality and accessibility. Efforts to increase the quality of data within the database included two major projects; one to identify and remove all vector contamination from sequences in the database and one to create premier sequence sets (including both alignments and discontiguous sequences). Data accessibility was improved during the course of the last year in several ways. First, a graphical database sequence viewer was made available to researchers. Second, an update process was implemented for the web-based query tool, Maestro. Third, a web-based tool, Excerpt, was developed to retrieve selected regions of any sequence in the database. And lastly, a GSDB flatfile that contains annotation unique to GSDB (e.g., sequence analysis and alignment data) was developed. Additionally, the GSDB web site provides a tool for the detection of matrix attachment regions (MARs), which can be used to identify regions of high coding potential. The ultimate goal of this work is to make GSDB a more useful resource for genomic comparison studies and gene level studies by improving data quality and by providing data access capabilities that are consistent with the needs of both types of studies.

[Effects of low pH and nicotine on carotid body chemoreceptor activity in the rabbit]

The unit discharges of carotid chemosensory afferent fibers were recorded in the in vitro carotid body (CB)--sinus nerve preparations (n = 55) from 29 rabbits. The results were as follows: (1) The discharge of all the units increased from 0.86 +/- 0.21 to 1.75 +/- 0.40 imp/s (P < 0.001) upon lowering the pH of modified Locke solution. (2) Addition of nicotine at doses of 1, 3, 6, 10 and 15 micrograms/ml to the solution led to a dose-dependent increase in the discharge from 0.60 +/- 0.21 to 0.96 +/- 0.21, 1.19 +/- 0.30. 1.24 +/- 0.29, 1.48 +/- 0.41 and 1.82 +/- 0.39 imp/s, respectively (r = 0.94, P < 0.001, n = 10). Nicotinic stimulation was antagonized by D-tubocurarine but the basal discharge was not significantly affected. (3) Superfusion of the CB with acid solution increased the discharge from 0.95 +/- 0.34 to 1.84 +/- 0.55 imp/s (P < 0.01, n = 19); After injections of nicotine 1-5 micrograms/ml to acid perfusate the unit discharge showed an increase from 0.96 +/- 0.25 to 1.53 +/- 0.24 imp/s. The degree of increase was less as compared with that due to mere acidification (P < 0.05). (4) D-tubocurarine did not alter the action of acid solution on chemosensory discharge (P > 0.05, n = 17). The present results suggest that ACh might act only as a modulator on carotid chemosensory activity without involving N-cholinergic receptor directly as did by low pH perfusion of CB.